Enterofuril capsules 200mg, No. 16
Expiration Date: 05/2027
Russian Pharmacy name:
Энтерофурил капсулы 200мг, №16
Common to all dosage forms
diarrhea of ??bacterial origin.
For oral suspension additionally
chronic lesions of the gastrointestinal tract of bacterial etiology, accompanied by dyspeptic symptoms.
Inside. Nifuroxazide therapy should not be continued for more than 7 days.
100 mg capsules
For adults and children over 7 years of age, the drug is prescribed for 2 caps. (200 mg) 4 times a day, the daily dose is 800 mg.
For children 3Ц7 years old, the drug is prescribed for 2 caps. (200 mg) 3 times a day, the daily dose is 600 mg.
200 mg capsules
For adults and children over 7 years of age, the drug is prescribed 1 capsule. (200 mg) 4 times a day, the daily dose is 800 mg.
For children 3Ц7 years old, the drug is prescribed 1 caps. (200 mg) 3 times a day, the daily dose is 600 mg.
Oral suspension
For dosing, a dosage spoon of 5 ml is used, having a graduation of 2.5 ml.
Shake the suspension well before use.
Children 1-6 months: 2.5 ml 2-3 times a day (with an interval of 8 to 12 hours).
Children 7 months - 2 years: 2.5 ml 4 times a day (with an interval of 8 hours).
Children 3-7 years old: 5 ml 3 times a day (with an interval of 8 hours).
Adults and children over 7 years old: 5 ml 3-4 times a day (with an interval of 6-8 hours).
| Capsules | 1 caps. |
| active substance: | |
| nifuroxazide | 100 mg |
| 200 mg | |
| excipients: sucrose - 36/71 mg; corn starch - 44/68 mg; MCC - 5.1 / 9 mg; magnesium stearate - 0.9 / 2 mg | |
| capsule shell, 100 mg: gelatin; titanium dioxide; dye quinoline yellow; dye azorubin; crimson dye [Ponso 4R] | |
| capsule shell, 200 mg: gelatin; titanium dioxide; iron dye oxide yellow |
| Oral suspension | 5 ml |
| active substance: | |
| nifuroxazide | 200 mg |
| excipients: sucrose - 1000 mg; sodium hydroxide - 2 mg; methyl parahydroxybenzoate - 5 mg; ethanol 96% - 0.05 ml; carbomer - 10.5 mg; citric acid - 0.75 mg; banana flavoring - 10 mg; water - up to 5 ml |
Common to all dosage forms
hypersensitivity to nitrofuran derivatives or other components of the drug;
fructose intolerance, glucose-galactose malabsorption syndrome or sucrase and isomaltase deficiency.
For oral suspension additionally
neonatal period (up to 1 month), prematurity.
For capsules additionally
children up to age 3 years.